Sus Clinicals

Cincinnati, United States

Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.

$3.5M raised

Jan 2024

Seed

Biotechnology Pharmaceutical Product Research

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sus Clinicals

How much funding has Sus Clinicals raised?

Sus Clinicals has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Where is Sus Clinicals headquartered?

Sus Clinicals is headquartered in Cincinnati, United States.

What does Sus Clinicals do?

Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.

What stage is Sus Clinicals at?

Sus Clinicals is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 10, 2024.

MLA

"Sus Clinicals — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/sus-clinicals. Accessed July 3, 2026.

APA

VCBacked. (2024). Sus Clinicals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/sus-clinicals

Wikipedia (cite web)

{{cite web |title=Sus Clinicals — Funding & Investors |url=https://www.vcbacked.co/company/sus-clinicals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 10, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K